Noreen Parsons
Senior Strategic Advisor Commercial Strategy
Noreen is an experienced industry executive with 25+ years of leading teams in global , regional and local commercial strategy and transformation, pricing and market access, new product planning , portfolio strategy, go -to -market/launch excellence & life cycle management. She has also led an access to medicines consulting business and held board positions for joint ventures in the biosimilar space.
Noreen believes in innovative, dynamic , collaborative and expertise- based approach to optimizing opportunities and problem-solving. She has worked across multiple therapy areas throughout her career and most recently has enjoyed global leadership roles in oncology and immunology.
Her academic qualifications span science and business with a BSc in Pharmacy (Portsmouth) and a MSc in Marketing ( Manchester) and an MBA (Lancaster).
Latest news
New Clarivate Report Reveals Mainland China as Emerging Global Biopharma Innovation Leader
Out-Licensing Deals Reach $50 Billion as Chinese Biopharma Innovators Drive Breakthrough Science LONDON, U.K. December 8, 2025 Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, in partnership…
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle London, U.K. — December 4, 2025 — Clarivate Plc…
Clarivate and the Chinese Academy of Sciences Release the 2025 Research Fronts Report
Annual report identifies 110 hot and 18 emerging Research Fronts London, U.K. December 3, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy…